nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—Topoisomerase Inhibitors—Mitoxantrone—lymphatic system cancer	0.77	1	CiPCiCtD
Teniposide—TOP2A—Mitoxantrone—lymphatic system cancer	0.0753	0.46	CbGbCtD
Teniposide—ABCG2—Mitoxantrone—lymphatic system cancer	0.0279	0.171	CbGbCtD
Teniposide—ABCG2—Vincristine—lymphatic system cancer	0.0192	0.117	CbGbCtD
Teniposide—ABCG2—Methotrexate—lymphatic system cancer	0.0116	0.0711	CbGbCtD
Teniposide—CYP3A5—Vincristine—lymphatic system cancer	0.0107	0.0651	CbGbCtD
Teniposide—CYP3A4—Cytarabine—lymphatic system cancer	0.00876	0.0535	CbGbCtD
Teniposide—CYP3A4—Mitoxantrone—lymphatic system cancer	0.00604	0.0369	CbGbCtD
Teniposide—CYP3A4—Vincristine—lymphatic system cancer	0.00415	0.0254	CbGbCtD
Teniposide—Gastrointestinal toxicity—Methotrexate—lymphatic system cancer	0.00105	0.0164	CcSEcCtD
Teniposide—Neurotoxicity—Vincristine—lymphatic system cancer	0.000918	0.0143	CcSEcCtD
Teniposide—Myelosuppression—Bleomycin—lymphatic system cancer	0.000911	0.0142	CcSEcCtD
Teniposide—Bone marrow depression—Fludarabine—lymphatic system cancer	0.000863	0.0135	CcSEcCtD
Teniposide—Myelosuppression—Carmustine—lymphatic system cancer	0.000795	0.0124	CcSEcCtD
Teniposide—Mucosal inflammation—Bleomycin—lymphatic system cancer	0.000772	0.012	CcSEcCtD
Teniposide—Myelosuppression—Vincristine—lymphatic system cancer	0.000759	0.0118	CcSEcCtD
Teniposide—Nephropathy toxic—Bleomycin—lymphatic system cancer	0.000744	0.0116	CcSEcCtD
Teniposide—Myelosuppression—Mitoxantrone—lymphatic system cancer	0.000739	0.0115	CcSEcCtD
Teniposide—NCOA3—Gemcitabine—Cytarabine—lymphatic system cancer	0.000733	0.375	CbGdCrCtD
Teniposide—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.000723	0.0113	CcSEcCtD
Teniposide—Sudden death—Mitoxantrone—lymphatic system cancer	0.000677	0.0106	CcSEcCtD
Teniposide—Nephropathy toxic—Carmustine—lymphatic system cancer	0.000649	0.0101	CcSEcCtD
Teniposide—Leukaemia—Methotrexate—lymphatic system cancer	0.000641	0.01	CcSEcCtD
Teniposide—Mucosal inflammation—Mitoxantrone—lymphatic system cancer	0.000626	0.00977	CcSEcCtD
Teniposide—Nephropathy toxic—Mitoxantrone—lymphatic system cancer	0.000604	0.00942	CcSEcCtD
Teniposide—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.000536	0.00836	CcSEcCtD
Teniposide—Bone marrow depression—Vincristine—lymphatic system cancer	0.000527	0.00823	CcSEcCtD
Teniposide—Bone marrow depression—Mitoxantrone—lymphatic system cancer	0.000513	0.00801	CcSEcCtD
Teniposide—Phlebitis—Fludarabine—lymphatic system cancer	0.000491	0.00766	CcSEcCtD
Teniposide—Extravasation—Bleomycin—lymphatic system cancer	0.00049	0.00764	CcSEcCtD
Teniposide—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.000454	0.00708	CcSEcCtD
Teniposide—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.000452	0.00705	CcSEcCtD
Teniposide—Neurotoxicity—Methotrexate—lymphatic system cancer	0.000445	0.00695	CcSEcCtD
Teniposide—Extravasation—Carmustine—lymphatic system cancer	0.000427	0.00667	CcSEcCtD
Teniposide—Extravasation—Vincristine—lymphatic system cancer	0.000408	0.00637	CcSEcCtD
Teniposide—Alopecia—Mechlorethamine—lymphatic system cancer	0.000399	0.00623	CcSEcCtD
Teniposide—Extravasation—Mitoxantrone—lymphatic system cancer	0.000397	0.0062	CcSEcCtD
Teniposide—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.00039	0.00609	CcSEcCtD
Teniposide—Raised liver function tests—Methotrexate—lymphatic system cancer	0.000374	0.00584	CcSEcCtD
Teniposide—Phlebitis—Bleomycin—lymphatic system cancer	0.00036	0.00562	CcSEcCtD
Teniposide—Leukopenia—Mechlorethamine—lymphatic system cancer	0.000352	0.00549	CcSEcCtD
Teniposide—Neuropathy—Carmustine—lymphatic system cancer	0.00035	0.00546	CcSEcCtD
Teniposide—Pancytopenia—Fludarabine—lymphatic system cancer	0.000347	0.00542	CcSEcCtD
Teniposide—Neutropenia—Fludarabine—lymphatic system cancer	0.000342	0.00533	CcSEcCtD
Teniposide—Sudden death—Methotrexate—lymphatic system cancer	0.000337	0.00527	CcSEcCtD
Teniposide—Neoplasm—Carmustine—lymphatic system cancer	0.000337	0.00526	CcSEcCtD
Teniposide—Neuropathy—Vincristine—lymphatic system cancer	0.000334	0.00521	CcSEcCtD
Teniposide—Sepsis—Carmustine—lymphatic system cancer	0.000324	0.00505	CcSEcCtD
Teniposide—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.000319	0.00498	CcSEcCtD
Teniposide—Infection—Mechlorethamine—lymphatic system cancer	0.000319	0.00497	CcSEcCtD
Teniposide—Stomatitis—Fludarabine—lymphatic system cancer	0.000318	0.00496	CcSEcCtD
Teniposide—Phlebitis—Carmustine—lymphatic system cancer	0.000314	0.0049	CcSEcCtD
Teniposide—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.000314	0.0049	CcSEcCtD
Teniposide—Mucosal inflammation—Methotrexate—lymphatic system cancer	0.000312	0.00487	CcSEcCtD
Teniposide—Anorexia—Mechlorethamine—lymphatic system cancer	0.000306	0.00477	CcSEcCtD
Teniposide—Sepsis—Mitoxantrone—lymphatic system cancer	0.000301	0.00469	CcSEcCtD
Teniposide—Haemoglobin—Fludarabine—lymphatic system cancer	0.000294	0.00459	CcSEcCtD
Teniposide—Haemorrhage—Fludarabine—lymphatic system cancer	0.000293	0.00456	CcSEcCtD
Teniposide—Phlebitis—Mitoxantrone—lymphatic system cancer	0.000292	0.00456	CcSEcCtD
Teniposide—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.000279	0.00435	CcSEcCtD
Teniposide—Bronchospasm—Bleomycin—lymphatic system cancer	0.000264	0.00411	CcSEcCtD
Teniposide—Chills—Fludarabine—lymphatic system cancer	0.000263	0.0041	CcSEcCtD
Teniposide—Arrhythmia—Fludarabine—lymphatic system cancer	0.000261	0.00408	CcSEcCtD
Teniposide—TOP2A—Vindesine—Vincristine—lymphatic system cancer	0.000261	0.133	CbGdCrCtD
Teniposide—Alopecia—Fludarabine—lymphatic system cancer	0.000259	0.00403	CcSEcCtD
Teniposide—Bone marrow depression—Methotrexate—lymphatic system cancer	0.000256	0.00399	CcSEcCtD
Teniposide—Pancytopenia—Bleomycin—lymphatic system cancer	0.000255	0.00397	CcSEcCtD
Teniposide—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00025	0.0039	CcSEcCtD
Teniposide—Cyanosis—Methotrexate—lymphatic system cancer	0.000244	0.00381	CcSEcCtD
Teniposide—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.000236	0.00369	CcSEcCtD
Teniposide—Anaemia—Fludarabine—lymphatic system cancer	0.000235	0.00367	CcSEcCtD
Teniposide—Agitation—Fludarabine—lymphatic system cancer	0.000234	0.00365	CcSEcCtD
Teniposide—Stomatitis—Bleomycin—lymphatic system cancer	0.000233	0.00363	CcSEcCtD
Teniposide—Leukopenia—Fludarabine—lymphatic system cancer	0.000228	0.00356	CcSEcCtD
Teniposide—Pruritus—Mechlorethamine—lymphatic system cancer	0.000227	0.00354	CcSEcCtD
Teniposide—Pancytopenia—Carmustine—lymphatic system cancer	0.000222	0.00347	CcSEcCtD
Teniposide—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000219	0.00342	CcSEcCtD
Teniposide—Neutropenia—Carmustine—lymphatic system cancer	0.000219	0.00341	CcSEcCtD
Teniposide—Haemoglobin—Bleomycin—lymphatic system cancer	0.000216	0.00336	CcSEcCtD
Teniposide—Haemorrhage—Bleomycin—lymphatic system cancer	0.000215	0.00335	CcSEcCtD
Teniposide—Pancytopenia—Vincristine—lymphatic system cancer	0.000212	0.00331	CcSEcCtD
Teniposide—Confusional state—Fludarabine—lymphatic system cancer	0.00021	0.00327	CcSEcCtD
Teniposide—Neutropenia—Vincristine—lymphatic system cancer	0.000209	0.00326	CcSEcCtD
Teniposide—Oedema—Fludarabine—lymphatic system cancer	0.000208	0.00324	CcSEcCtD
Teniposide—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000207	0.00322	CcSEcCtD
Teniposide—Infection—Fludarabine—lymphatic system cancer	0.000206	0.00322	CcSEcCtD
Teniposide—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.000204	0.00319	CcSEcCtD
Teniposide—Vomiting—Mechlorethamine—lymphatic system cancer	0.000204	0.00318	CcSEcCtD
Teniposide—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000204	0.00318	CcSEcCtD
Teniposide—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000203	0.00317	CcSEcCtD
Teniposide—Stomatitis—Carmustine—lymphatic system cancer	0.000203	0.00317	CcSEcCtD
Teniposide—Rash—Mechlorethamine—lymphatic system cancer	0.000202	0.00316	CcSEcCtD
Teniposide—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000202	0.00315	CcSEcCtD
Teniposide—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000201	0.00314	CcSEcCtD
Teniposide—Flushing—Bleomycin—lymphatic system cancer	0.000199	0.00311	CcSEcCtD
Teniposide—Anorexia—Fludarabine—lymphatic system cancer	0.000198	0.00309	CcSEcCtD
Teniposide—Extravasation—Methotrexate—lymphatic system cancer	0.000198	0.00309	CcSEcCtD
Teniposide—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000195	0.00305	CcSEcCtD
Teniposide—Stomatitis—Vincristine—lymphatic system cancer	0.000194	0.00303	CcSEcCtD
Teniposide—Chills—Bleomycin—lymphatic system cancer	0.000192	0.003	CcSEcCtD
Teniposide—Sweating—Vincristine—lymphatic system cancer	0.000191	0.00298	CcSEcCtD
Teniposide—Nausea—Mechlorethamine—lymphatic system cancer	0.000191	0.00297	CcSEcCtD
Teniposide—Alopecia—Bleomycin—lymphatic system cancer	0.00019	0.00296	CcSEcCtD
Teniposide—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000189	0.00295	CcSEcCtD
Teniposide—Haemoglobin—Carmustine—lymphatic system cancer	0.000188	0.00294	CcSEcCtD
Teniposide—Haemorrhage—Carmustine—lymphatic system cancer	0.000187	0.00292	CcSEcCtD
Teniposide—Sweating—Mitoxantrone—lymphatic system cancer	0.000186	0.0029	CcSEcCtD
Teniposide—Dyspnoea—Fludarabine—lymphatic system cancer	0.000185	0.00289	CcSEcCtD
Teniposide—Decreased appetite—Fludarabine—lymphatic system cancer	0.000181	0.00282	CcSEcCtD
Teniposide—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000175	0.00273	CcSEcCtD
Teniposide—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000174	0.00272	CcSEcCtD
Teniposide—Flushing—Carmustine—lymphatic system cancer	0.000174	0.00271	CcSEcCtD
Teniposide—Anaemia—Bleomycin—lymphatic system cancer	0.000173	0.00269	CcSEcCtD
Teniposide—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000171	0.00267	CcSEcCtD
Teniposide—Arrhythmia—Carmustine—lymphatic system cancer	0.000167	0.00261	CcSEcCtD
Teniposide—Leukopenia—Bleomycin—lymphatic system cancer	0.000167	0.00261	CcSEcCtD
Teniposide—Alopecia—Carmustine—lymphatic system cancer	0.000165	0.00258	CcSEcCtD
Teniposide—TOP2A—Vinorelbine—Vincristine—lymphatic system cancer	0.000164	0.0842	CbGdCrCtD
Teniposide—Body temperature increased—Fludarabine—lymphatic system cancer	0.000164	0.00256	CcSEcCtD
Teniposide—Chest pain—Bleomycin—lymphatic system cancer	0.000159	0.00248	CcSEcCtD
Teniposide—Alopecia—Vincristine—lymphatic system cancer	0.000158	0.00246	CcSEcCtD
Teniposide—Chills—Mitoxantrone—lymphatic system cancer	0.000156	0.00244	CcSEcCtD
Teniposide—Neoplasm—Methotrexate—lymphatic system cancer	0.000156	0.00244	CcSEcCtD
Teniposide—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000156	0.00243	CcSEcCtD
Teniposide—Alopecia—Mitoxantrone—lymphatic system cancer	0.000154	0.0024	CcSEcCtD
Teniposide—Confusional state—Bleomycin—lymphatic system cancer	0.000154	0.0024	CcSEcCtD
Teniposide—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000153	0.00239	CcSEcCtD
Teniposide—Oedema—Bleomycin—lymphatic system cancer	0.000152	0.00238	CcSEcCtD
Teniposide—Infection—Bleomycin—lymphatic system cancer	0.000151	0.00236	CcSEcCtD
Teniposide—Anaemia—Carmustine—lymphatic system cancer	0.000151	0.00235	CcSEcCtD
Teniposide—Sepsis—Methotrexate—lymphatic system cancer	0.00015	0.00234	CcSEcCtD
Teniposide—Agitation—Carmustine—lymphatic system cancer	0.00015	0.00234	CcSEcCtD
Teniposide—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000149	0.00233	CcSEcCtD
Teniposide—Asthenia—Fludarabine—lymphatic system cancer	0.000149	0.00233	CcSEcCtD
Teniposide—Pruritus—Fludarabine—lymphatic system cancer	0.000147	0.00229	CcSEcCtD
Teniposide—Leukopenia—Carmustine—lymphatic system cancer	0.000146	0.00228	CcSEcCtD
Teniposide—Anorexia—Bleomycin—lymphatic system cancer	0.000145	0.00227	CcSEcCtD
Teniposide—Anaemia—Vincristine—lymphatic system cancer	0.000144	0.00224	CcSEcCtD
Teniposide—Agitation—Vincristine—lymphatic system cancer	0.000143	0.00223	CcSEcCtD
Teniposide—Hypotension—Bleomycin—lymphatic system cancer	0.000142	0.00222	CcSEcCtD
Teniposide—Diarrhoea—Fludarabine—lymphatic system cancer	0.000142	0.00222	CcSEcCtD
Teniposide—Hypertension—Carmustine—lymphatic system cancer	0.000141	0.0022	CcSEcCtD
Teniposide—Anaemia—Mitoxantrone—lymphatic system cancer	0.00014	0.00219	CcSEcCtD
Teniposide—Leukopenia—Vincristine—lymphatic system cancer	0.000139	0.00217	CcSEcCtD
Teniposide—Chest pain—Carmustine—lymphatic system cancer	0.000139	0.00217	CcSEcCtD
Teniposide—Dyspnoea—Bleomycin—lymphatic system cancer	0.000136	0.00212	CcSEcCtD
Teniposide—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000136	0.00212	CcSEcCtD
Teniposide—Hypertension—Vincristine—lymphatic system cancer	0.000134	0.0021	CcSEcCtD
Teniposide—Confusional state—Carmustine—lymphatic system cancer	0.000134	0.00209	CcSEcCtD
Teniposide—Oedema—Carmustine—lymphatic system cancer	0.000133	0.00208	CcSEcCtD
Teniposide—Decreased appetite—Bleomycin—lymphatic system cancer	0.000132	0.00207	CcSEcCtD
Teniposide—Infection—Carmustine—lymphatic system cancer	0.000132	0.00206	CcSEcCtD
Teniposide—Vomiting—Fludarabine—lymphatic system cancer	0.000132	0.00206	CcSEcCtD
Teniposide—Rash—Fludarabine—lymphatic system cancer	0.000131	0.00204	CcSEcCtD
Teniposide—Dermatitis—Fludarabine—lymphatic system cancer	0.000131	0.00204	CcSEcCtD
Teniposide—Hypertension—Mitoxantrone—lymphatic system cancer	0.000131	0.00204	CcSEcCtD
Teniposide—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00013	0.00203	CcSEcCtD
Teniposide—Headache—Fludarabine—lymphatic system cancer	0.00013	0.00203	CcSEcCtD
Teniposide—Tachycardia—Carmustine—lymphatic system cancer	0.00013	0.00203	CcSEcCtD
Teniposide—Chest pain—Mitoxantrone—lymphatic system cancer	0.000129	0.00201	CcSEcCtD
Teniposide—Oedema—Vincristine—lymphatic system cancer	0.000127	0.00198	CcSEcCtD
Teniposide—Anorexia—Carmustine—lymphatic system cancer	0.000127	0.00198	CcSEcCtD
Teniposide—Infection—Vincristine—lymphatic system cancer	0.000126	0.00197	CcSEcCtD
Teniposide—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000126	0.00196	CcSEcCtD
Teniposide—Confusional state—Mitoxantrone—lymphatic system cancer	0.000125	0.00195	CcSEcCtD
Teniposide—TOP2A—Cladribine—Fludarabine—lymphatic system cancer	0.000124	0.0637	CbGdCrCtD
Teniposide—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000124	0.00194	CcSEcCtD
Teniposide—Hypotension—Carmustine—lymphatic system cancer	0.000124	0.00194	CcSEcCtD
Teniposide—Oedema—Mitoxantrone—lymphatic system cancer	0.000124	0.00193	CcSEcCtD
Teniposide—Nausea—Fludarabine—lymphatic system cancer	0.000123	0.00193	CcSEcCtD
Teniposide—Infection—Mitoxantrone—lymphatic system cancer	0.000123	0.00192	CcSEcCtD
Teniposide—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000123	0.00192	CcSEcCtD
Teniposide—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000121	0.00189	CcSEcCtD
Teniposide—Urticaria—Bleomycin—lymphatic system cancer	0.000121	0.00189	CcSEcCtD
Teniposide—Anorexia—Vincristine—lymphatic system cancer	0.000121	0.00189	CcSEcCtD
Teniposide—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000121	0.00188	CcSEcCtD
Teniposide—Body temperature increased—Bleomycin—lymphatic system cancer	0.00012	0.00188	CcSEcCtD
Teniposide—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00012	0.00187	CcSEcCtD
Teniposide—Hypotension—Vincristine—lymphatic system cancer	0.000119	0.00185	CcSEcCtD
Teniposide—Dyspnoea—Carmustine—lymphatic system cancer	0.000119	0.00185	CcSEcCtD
Teniposide—Anorexia—Mitoxantrone—lymphatic system cancer	0.000118	0.00184	CcSEcCtD
Teniposide—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000116	0.00181	CcSEcCtD
Teniposide—Decreased appetite—Carmustine—lymphatic system cancer	0.000116	0.0018	CcSEcCtD
Teniposide—Hypotension—Mitoxantrone—lymphatic system cancer	0.000116	0.0018	CcSEcCtD
Teniposide—TOP2A—Clofarabine—Fludarabine—lymphatic system cancer	0.000115	0.0589	CbGdCrCtD
Teniposide—TOP2A—Vinblastine—Vincristine—lymphatic system cancer	0.000113	0.0579	CbGdCrCtD
Teniposide—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000112	0.00175	CcSEcCtD
Teniposide—Decreased appetite—Vincristine—lymphatic system cancer	0.00011	0.00172	CcSEcCtD
Teniposide—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00011	0.00172	CcSEcCtD
Teniposide—Feeling abnormal—Carmustine—lymphatic system cancer	0.00011	0.00171	CcSEcCtD
Teniposide—Asthenia—Bleomycin—lymphatic system cancer	0.000109	0.00171	CcSEcCtD
Teniposide—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000109	0.0017	CcSEcCtD
Teniposide—TOP2A—Clofarabine—Cytarabine—lymphatic system cancer	0.000109	0.0556	CbGdCrCtD
Teniposide—Pruritus—Bleomycin—lymphatic system cancer	0.000108	0.00168	CcSEcCtD
Teniposide—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000108	0.00168	CcSEcCtD
Teniposide—Body temperature increased—Carmustine—lymphatic system cancer	0.000105	0.00164	CcSEcCtD
Teniposide—Abdominal pain—Carmustine—lymphatic system cancer	0.000105	0.00164	CcSEcCtD
Teniposide—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000104	0.00162	CcSEcCtD
Teniposide—Pancytopenia—Methotrexate—lymphatic system cancer	0.000103	0.00161	CcSEcCtD
Teniposide—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000102	0.00159	CcSEcCtD
Teniposide—Neutropenia—Methotrexate—lymphatic system cancer	0.000101	0.00158	CcSEcCtD
Teniposide—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000101	0.00158	CcSEcCtD
Teniposide—TOP2A—Gemcitabine—Cytarabine—lymphatic system cancer	0.000101	0.0515	CbGdCrCtD
Teniposide—Body temperature increased—Vincristine—lymphatic system cancer	0.0001	0.00157	CcSEcCtD
Teniposide—Abdominal pain—Vincristine—lymphatic system cancer	0.0001	0.00157	CcSEcCtD
Teniposide—Urticaria—Mitoxantrone—lymphatic system cancer	9.82e-05	0.00153	CcSEcCtD
Teniposide—Hypersensitivity—Carmustine—lymphatic system cancer	9.8e-05	0.00153	CcSEcCtD
Teniposide—TOP2A—Cytarabine—Fludarabine—lymphatic system cancer	9.79e-05	0.0501	CbGdCrCtD
Teniposide—Body temperature increased—Mitoxantrone—lymphatic system cancer	9.78e-05	0.00153	CcSEcCtD
Teniposide—Abdominal pain—Mitoxantrone—lymphatic system cancer	9.78e-05	0.00153	CcSEcCtD
Teniposide—Vomiting—Bleomycin—lymphatic system cancer	9.69e-05	0.00151	CcSEcCtD
Teniposide—Rash—Bleomycin—lymphatic system cancer	9.61e-05	0.0015	CcSEcCtD
Teniposide—Dermatitis—Bleomycin—lymphatic system cancer	9.6e-05	0.0015	CcSEcCtD
Teniposide—Asthenia—Carmustine—lymphatic system cancer	9.54e-05	0.00149	CcSEcCtD
Teniposide—Stomatitis—Methotrexate—lymphatic system cancer	9.42e-05	0.00147	CcSEcCtD
Teniposide—Hypersensitivity—Vincristine—lymphatic system cancer	9.36e-05	0.00146	CcSEcCtD
Teniposide—Sweating—Methotrexate—lymphatic system cancer	9.26e-05	0.00145	CcSEcCtD
Teniposide—Hypersensitivity—Mitoxantrone—lymphatic system cancer	9.11e-05	0.00142	CcSEcCtD
Teniposide—Asthenia—Vincristine—lymphatic system cancer	9.11e-05	0.00142	CcSEcCtD
Teniposide—Diarrhoea—Carmustine—lymphatic system cancer	9.1e-05	0.00142	CcSEcCtD
Teniposide—Nausea—Bleomycin—lymphatic system cancer	9.05e-05	0.00141	CcSEcCtD
Teniposide—Asthenia—Mitoxantrone—lymphatic system cancer	8.87e-05	0.00138	CcSEcCtD
Teniposide—Haemoglobin—Methotrexate—lymphatic system cancer	8.72e-05	0.00136	CcSEcCtD
Teniposide—Diarrhoea—Vincristine—lymphatic system cancer	8.69e-05	0.00136	CcSEcCtD
Teniposide—Haemorrhage—Methotrexate—lymphatic system cancer	8.67e-05	0.00135	CcSEcCtD
Teniposide—Diarrhoea—Mitoxantrone—lymphatic system cancer	8.46e-05	0.00132	CcSEcCtD
Teniposide—Vomiting—Carmustine—lymphatic system cancer	8.46e-05	0.00132	CcSEcCtD
Teniposide—Rash—Carmustine—lymphatic system cancer	8.39e-05	0.00131	CcSEcCtD
Teniposide—Dermatitis—Carmustine—lymphatic system cancer	8.38e-05	0.00131	CcSEcCtD
Teniposide—Headache—Carmustine—lymphatic system cancer	8.33e-05	0.0013	CcSEcCtD
Teniposide—Vomiting—Vincristine—lymphatic system cancer	8.07e-05	0.00126	CcSEcCtD
Teniposide—Rash—Vincristine—lymphatic system cancer	8.01e-05	0.00125	CcSEcCtD
Teniposide—Dermatitis—Vincristine—lymphatic system cancer	8e-05	0.00125	CcSEcCtD
Teniposide—Headache—Vincristine—lymphatic system cancer	7.96e-05	0.00124	CcSEcCtD
Teniposide—Nausea—Carmustine—lymphatic system cancer	7.9e-05	0.00123	CcSEcCtD
Teniposide—Vomiting—Mitoxantrone—lymphatic system cancer	7.86e-05	0.00123	CcSEcCtD
Teniposide—Rash—Mitoxantrone—lymphatic system cancer	7.8e-05	0.00122	CcSEcCtD
Teniposide—Dermatitis—Mitoxantrone—lymphatic system cancer	7.79e-05	0.00122	CcSEcCtD
Teniposide—Chills—Methotrexate—lymphatic system cancer	7.78e-05	0.00121	CcSEcCtD
Teniposide—Headache—Mitoxantrone—lymphatic system cancer	7.75e-05	0.00121	CcSEcCtD
Teniposide—Alopecia—Methotrexate—lymphatic system cancer	7.66e-05	0.0012	CcSEcCtD
Teniposide—Nausea—Vincristine—lymphatic system cancer	7.54e-05	0.00118	CcSEcCtD
Teniposide—Nausea—Mitoxantrone—lymphatic system cancer	7.35e-05	0.00115	CcSEcCtD
Teniposide—TOP2A—Azacitidine—Fludarabine—lymphatic system cancer	7.02e-05	0.0359	CbGdCrCtD
Teniposide—Anaemia—Methotrexate—lymphatic system cancer	6.98e-05	0.00109	CcSEcCtD
Teniposide—Leukopenia—Methotrexate—lymphatic system cancer	6.76e-05	0.00105	CcSEcCtD
Teniposide—TOP2A—Azacitidine—Cytarabine—lymphatic system cancer	6.63e-05	0.0339	CbGdCrCtD
Teniposide—Chest pain—Methotrexate—lymphatic system cancer	6.43e-05	0.001	CcSEcCtD
Teniposide—Confusional state—Methotrexate—lymphatic system cancer	6.21e-05	0.000969	CcSEcCtD
Teniposide—Infection—Methotrexate—lymphatic system cancer	6.12e-05	0.000955	CcSEcCtD
Teniposide—Thrombocytopenia—Methotrexate—lymphatic system cancer	6.03e-05	0.000941	CcSEcCtD
Teniposide—Hyperhidrosis—Methotrexate—lymphatic system cancer	5.96e-05	0.000929	CcSEcCtD
Teniposide—Anorexia—Methotrexate—lymphatic system cancer	5.87e-05	0.000916	CcSEcCtD
Teniposide—Hypotension—Methotrexate—lymphatic system cancer	5.76e-05	0.000898	CcSEcCtD
Teniposide—Dyspnoea—Methotrexate—lymphatic system cancer	5.49e-05	0.000857	CcSEcCtD
Teniposide—Decreased appetite—Methotrexate—lymphatic system cancer	5.36e-05	0.000836	CcSEcCtD
Teniposide—Feeling abnormal—Methotrexate—lymphatic system cancer	5.08e-05	0.000792	CcSEcCtD
Teniposide—Gastrointestinal pain—Methotrexate—lymphatic system cancer	5.04e-05	0.000786	CcSEcCtD
Teniposide—Urticaria—Methotrexate—lymphatic system cancer	4.9e-05	0.000764	CcSEcCtD
Teniposide—Abdominal pain—Methotrexate—lymphatic system cancer	4.87e-05	0.00076	CcSEcCtD
Teniposide—Body temperature increased—Methotrexate—lymphatic system cancer	4.87e-05	0.00076	CcSEcCtD
Teniposide—Hypersensitivity—Methotrexate—lymphatic system cancer	4.54e-05	0.000708	CcSEcCtD
Teniposide—Asthenia—Methotrexate—lymphatic system cancer	4.42e-05	0.00069	CcSEcCtD
Teniposide—Pruritus—Methotrexate—lymphatic system cancer	4.36e-05	0.00068	CcSEcCtD
Teniposide—Diarrhoea—Methotrexate—lymphatic system cancer	4.22e-05	0.000658	CcSEcCtD
Teniposide—Vomiting—Methotrexate—lymphatic system cancer	3.92e-05	0.000611	CcSEcCtD
Teniposide—Rash—Methotrexate—lymphatic system cancer	3.89e-05	0.000606	CcSEcCtD
Teniposide—Dermatitis—Methotrexate—lymphatic system cancer	3.88e-05	0.000606	CcSEcCtD
Teniposide—Headache—Methotrexate—lymphatic system cancer	3.86e-05	0.000602	CcSEcCtD
Teniposide—Nausea—Methotrexate—lymphatic system cancer	3.66e-05	0.000571	CcSEcCtD
